Stay updated on Selpercatinib in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Selpercatinib in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Selpercatinib in Advanced Solid Tumors Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe page now displays a 403 Forbidden error instead of showing the study content, indicating access is blocked to the NCT03157128 record. This reflects an access-control issue rather than an update to the study data.SummaryDifference23%

- Check14 days agoChange DetectedThe page's revision label updated from v3.6.6 to v3.7.0, indicating an updated version of the page. This is an administrative update rather than a substantive content change.SummaryDifference0.0%

- Check28 days agoChange DetectedA new revision tag, v3.6.6, appears, replacing the prior v3.6.5, indicating a minor update to the page's versioning.SummaryDifference0.0%

- Check35 days agoChange DetectedTwo NIH grant/contract lines for 2017 and 2023 were added to the study record, reflecting funding support for the LIBRETTO-001 study.SummaryDifference0.0%

- Check50 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5, signaling a newer revision of the page content. This change reflects an update to the page's metadata rather than to the study information.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page update changes the site revision from v3.6.3 to v3.6.4, indicating a deployment or patch.SummaryDifference0.0%

Stay in the know with updates to Selpercatinib in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selpercatinib in Advanced Solid Tumors Clinical Trial page.